Constructing of a scientific fitness literacy evaluation model for adults (preprint)

COVID-19-associated lockdown has been implemented worldwide, potentially causing unfavorable changes in lifestyle and psychological health. Physical literacy, healthy diets, and lifestyles play important roles in mitigating the adverse effects. Therefore, this study aimed to enable individuals to understand their fitness literacy and establish a personalized exercise plan. In this study, 903 adults aged 19－59 were surveyed based on the concept of scientific fitness literacy and the influencing factors in the context of the effective containment of COVID-19 before (2019) and during (2020) the pandemic. This study screened four factors from four dimensions–cognition, attitude, ability and skills, and behavior and habits–that can influence adults' scientific fitness literacy. Confirmatory factor analysis (CFA) and AMOS software were used to construct an evaluation index system of scientific fitness literacy for adults. The model consisting 10 items with 4 factors to evaluation index system has good overall fitness, reliability, convergent validity, differential validity, and model stability and was able to analyze the factors that affect the scientific fitness literacy of individuals from different perspectives. This allowed individuals at different stages to have a deeper understanding of scientific fitness literacy.

Evaluation and Influencing Factor Analysis of Sustainable Green Transformation Efficiency of Resource-Based Cities in Western China in the Post-COVID-19 Era.

Under the impact of the coronavirus disease 2019 (COVID-19), green, low-carbon, and sustainable development has become a global consensus, and the world will enter a low-carbon and intelligent production mode faster. As the largest contributor to world economic growth and an active participant in global environmental governance, achieving green recovery and the high-quality economic and social development of China is of great significance to promote the global sustainable development strategy. The green transformation of resource-based cities in Western China is the key factor for China to build a high-quality modern economic system and promote long-term sustainable development. This article used the Super Efficiency Slack Based Model (Super-SBM) model and Malmquist index model of the Data Envelope Analysis (DEA) method to measure the static and dynamic green transformation efficiency of resource-based cities in Western China. It investigated the impact of different factors on the static and dynamic efficiency by constructing panel Tobit and dynamic panel models. The research found that the static efficiency of the green transformation of resource-based cities in Western China is low, and the development is uneven. The dynamic efficiency of green transformation showed a fluctuating upward trend first and an accelerating upward trend later. Different factors have different effects on green transformation efficiency. This article holds that the combination of post-epidemic economic recovery and green transformation is expected to promote the green transformation of western resource-based cities while injecting new vitality into China's green sustainable development in the post-COVID-19 era.

Scrutiny of human lung infection by SARS-CoV-2 and associated human immune responses in humanized mice (preprint)

There is an urgent need for animal models of COVID-19 to study immunopathogenesis and test therapeutic intervenes. In this study we showed that NSG mice engrafted with human lung (HL) tissue (NSG-L) could be infected efficiently by SARS-CoV-2, and that live virus capable of infecting Vero cells was found in the HL grafts and multiple organs from infected NSG-L mice. RNA-seq examination identified a series of differentially expressed genes, which are enriched in viral defense responses, chemotaxis, interferon stimulation, and pulmonary fibrosis between HL grafts from infected and control NSG-L mice. Furthermore, when infecting humanized mice with human immune system (HIS) and autologous HL grafts (HISL mice), the mice had bodyweight loss and hemorrhage and immune cell infiltration in HL grafts, which were not observed in immunodeficient NSG-L mice, indicating the development of anti-viral immune responses in these mice. In support of this possibility, the infected HISL mice showed bodyweight recovery and lack of detectable live virus at the later time. These results demonstrate that NSG-L and HISL mice are susceptible to SARS-CoV-2 infection, offering a useful in vivo model for studying SARS-CoV-2 infection and the associated immune response and immunopathology, and testing anti-SARS-CoV-2 therapies.

Impact of COVID-19 Pandemic on Intervals and Outcomes of Repeated Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma.

PURPOSE: Given that the novel coronavirus disease (COVID-19) pandemic has disrupted operations globally, an institution's ability to repeat transarterial chemoembolization (TACE) for patients with hepatocellular carcinoma (HCC) has also been affected. The aim of this study was to evaluate the impact of the COVID-19 on the intervals and outcomes of TACE in HCC patients. MATERIALS AND METHODS: This retrospective study included 154 HCC patients who underwent follow-up after TACE treatment from January 2020 to March 2020 (n = 71, study group) and January 2019 to March 2019 (n = 83, control group) at two institutions in China. The endpoints included the follow-up interval and overall response rate (ORR). Multivariate logistic regression analyses were performed to identify independent risk factors for a worse ORR. The cut-off point was determined to divide follow-up durations into long- and short-intervals. RESULTS: The median follow-up interval was 82.0 days (IQR, 61-109) in the study group, which was significantly longer than 66.0 days (IQR, 51-94) in the control group (P = 0.004). The ORR was 23.9 and 39.8% in the study and control group, respectively (P = 0.037). The cut-off value was 95 days. The grouping (OR, 2.402; 95% CI, 1.040-5.546; P = 0.040), long interval (OR, 2.573; 95% CI, 1.022-6.478; P = 0.045), and China liver cancer staging system (OR, 2.500; 95% CI, 1.797-3.480; P <0.001) were independent predictors for the efficacy of TACE treatment. CONCLUSIONS: The COVID-19 pandemic causes a longer follow-up interval in general, which may further lead to a lower ORR in HCC patients. Those with a follow-up interval of >95 days tend to have a worse prognosis.

Impact of the COVID−19 Pandemic on Farm Households’ Vulnerability to Multidimensional Poverty in Rural China

The COVID−19 pandemic has significantly impacted the economy and livelihoods of people worldwide. To analyze the impact of the pandemic on material conditions, income levels, health conditions, industrial development and employment opportunities of farmers in China’s rural areas, especially poor areas and explore whether farmers can achieve stable poverty eradication during the COVID−19 pandemic, we interviewed 2662 farm households in poverty−stricken areas of China and used the multidimensional poverty measurement model, three−step feasible generalized least squares and propensity score matching to analyze data. We achieved the following results. First, the overall level of multidimensional poverty vulnerability index (MPVI) of the surveyed households was low and the MPVI of each dimension varied significantly. The MPVI of households in the treated group was higher than that of the control group. Second, COVID−19 increased farm households’ vulnerability to multidimensional poverty in poverty−stricken regions;MPVI increased by 27.9%. Third, COVID−19′s impact on various dimensions differed: the greatest impact was on the vulnerability to health deprivation, followed by industrial development, employment and income deprivation. However, the pandemic slightly reduced the vulnerability to material deprivation. Finally, we proposed various measures in response to the impact of the pandemic to assist farm households in poverty−stricken areas.

Discovery of Pre-Existing Drugs that Suppress the Replication of SARS-CoV-2 in Vitro (preprint)

SARS-CoV-2, the causative agent of coronavirus disease 19 (COVID 19), is responsible for the ongoing pandemic but still lacks approved antivirals. Repurposing pre-existing FDA approved drugs presents a rapid approach for new therapeutic options. In the present study, we report that three pre-existing FDA-approved drugs, i.e., vapreotide, grazoprevir, and simeprevir, inhibit the replication of SARS-CoV-2 in cells. The E50 values of vapreotide, grazoprevir, and simeprevir against SARS-CoV-2 in Vero E6 cells was 3.98 ± 0.35 μM, 2.08 ± 0.13 μM, and 1.41 ± 0.12 μM, respectively. In vitro biochemical experiments further revealed that vapreotide, grazoprevir, and simeprevir efficiently inhibits the unwinding activity of the Nsp13 helicase of SARS-CoV-2 with IC50 values of ⁓10, ⁓2.5, and ⁓1.25 µM, respectively, providing signs for understanding their antiviral mechanism of action. Given their good safety profiles in their original indications, our study offices new insights in repurposing these drugs alone or in combination with other antivirals in the global fighting against SARS-CoV-2.Funding: This work was financially supported by the Youth Innovation Promotion Association CAS (to H.Y.), and the National Natural Science Foundation of China (No. 31770192 and No. 32070187 to H.Y.).Conflict of Interest: The authors declare no competing interests.

Impact of COVID-19 Pandemic on Intervals and Outcomes of Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma (preprint)

Background: Transarterial chemoembolization (TACE) may not be repeated “on-demand” timely for hepatocellular carcinoma (HCC) patients in the era of the novel coronavirus disease (COVID-19). We aim to evaluate the impact of the COVID-19 pandemic on the intervals and outcomes of TACE in HCC patients. Methods: This retrospective study included HCC patients who underwent TACE from Jan 1, 2020 to March 31, 2020 (study group) and Jan 1, 2019 to Mar 31, 2019 (control group) at two institutions in China. The endpoints included the TACE interval and the overall response rate (ORR). Uni- and multivariate logistic analyses were performed to identify independent risk factors associated with a worse ORR. The cut-off point was determined to divide repeated TACE time into long- and short- intervals. Findings: 154 patients (71 in the study group, 83 in the control group) were enrolled. The median TACE interval in the study group was 82·0 days (IQR, 61–109), longer than 66·0 days (IQR, 51–94) in the control group (p=0·004). The ORR was 23·9% in the study group, while 39·8% in the control group (p=0·037). The cut-off value was 95 days. The group (OR, 2·402; 95% CI, 1·040–5·546; p=0·040), the long interval (OR, 2·573; 95% CI, 1·022–6·478; p=0·045), and the stage system (OR, 2·500; 95% CI, 1·797–3·480; p<0·001) were independent predictors. Interpretation: For HCC patients, the COVID-19 pandemic results in a longer re-TACE schedule, which may further lead to a lower ORR. Patients with a TACE interval of more than 95 days may have a worse prognosis. Funding: This study was supported by the National Key Research and Development Project of China (2018YFA0704100), the National Natural Science Foundation of China (Major Scientific Research Instrument Development Program 81827805, 81441054, 81520108015, 81671796, 81901847), Jiangsu Provincial Medical Youth Talent Program (ZDRCA2016078), the Key Research and Development Project of Jiangsu Province (BE2019750), the Natural Science Foundation of Jiangsu Province (BK20190177), Innovation Platform of Jiangsu Provincial Medical Center (YXZXA2016005), and the Suzhou Science and Technology Youth Plan (KJXW2018003).Declaration of Interests: All authors declare no competing interests.Ethics Approval Statement: The study was approved by the institutional ethics review boards in two participating institutions and the requirement for written informed consent was waived due to its retrospective nature.

Advantages of anti-inflammatory acupuncture in treating sepsis of coronavirus disease 2019

Background: Sepsis is one of the most serious complications and a leading cause of death in patients with coronavirus disease 2019 (COVID-19). In general, it is the result of an unregulated inflammatory cascade such as a postinfection 'cytokine storm.' The conventional treatment mainly relies on glucocorticoids, of which curative effects are not ideal, as they come with significant side effects. It is critical to seek or develop other effective therapeutics in dealing cytokine storm to fight COVID-19 with sepsis. Aims and Objectives: Raise awareness of the significance applying anti-inflammatory acupuncture in dealing COVID-19 patients with sepsis and provide an appropriate acupuncture protocol that can be easily integrated into existing medical guideline. Materials and Methods: Current evidences from animal experiments and clinical trials about acupuncture in treating infectious sepsis are reviewed, and a detailed discussion on advantages of anti-inflammatory acupuncture is followed, then the rationality on the point selection and stimulation parameters of acupuncture is analyzed to propose an appropriate acupuncture protocol. Results: Current experiments have shown that acupuncture can play a significant role to improve inflammation reaction and reduce mortality in infectious animal and patients with sepsis and its mechanisms are mainly achieved by stimulating the vagus-cholinergic anti-inflammatory pathways. Applying acupuncture in treating COVID-19 patients with sepsis has four aspects of advantages. Moreover, a simple and convenient clinical acupuncture protocol including point selection and appropriate stimulation parameters is proposed. Conclusion: Acupuncture, especially electroacupuncture, has shown potentials in effectively treating infectious sepsis of animal models and critically ill patients in small sample studies by stimulating the nervous system, but has been largely overlooked in the clinic so far. It is advised that acupuncture should be integrated into the existing medical guidelines in dealing with COVID-19 complicated with sepsis.